Acknowledgement
본 연구는 2021년도 원광대학교 교비 지원에 의하여 연구되었음.
References
- Guthrie RA, Guthrie DW. Pathophysiology of diabetes mellitus. Crit Care Nurs Q. 2004;27(2):113-25. https://doi.org/10.1097/00002727-200404000-00003
- Arneth B, Arneth R, Shams M. Metabolomics of Type 1 and Type 2 Diabetes. Int J Mol Sci. 2019;20(10):2467. doi:10.3390/ ijms20102467.
- Zaccardi F, Webb DR, Yates T, Davies MJ. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 2016;92(1084):63-9. https://doi.org/10.1136/postgradmedj-2015-133281
- Henning RJ. Type-2 diabetes mellitus and cardiovascular disease. Future Cardiol. 2018;14(6):491-509. https://doi.org/10.2217/fca-2018-0045
- Balakumar P, Maung-U K, Jagadeesh G. Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res. 2016;113(Pt A):600-9. https://doi.org/10.1016/j.phrs.2016.09.040
- Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293-302. https://doi.org/10.1038/nrendo.2014.29
- Xie F, Chan JC, Ma RC. Precision medicine in diabetes prevention, classification and management. J Diabetes Investig. 2018;9(5): 998-1015. https://doi.org/10.1111/jdi.12830
- Ibrahim M, Tuomilehto J, Aschner P, et al. Global status of diabetes prevention and prospects for action: A consensus statement. Diabetes Metab Res Rev. 2018;34(6):e3021. doi:10.1002/ dmrr.3021.
- Davoren P. Glucose-lowering medicines for type 2 diabetes. Aust Fam Physician. 2015;44(5):176-9.
- Kashyap H, Gupta S, Bist R. Impact of Active Antihyperglycemic Components as Herbal Therapy for Preventive Health Care Management of Diabetes. Curr Mol Med. 2019;19(1):12-9. https://doi.org/10.2174/1566524019666190219124301
- Saimei Li, Peizheng Lin. Recent Status of "Dampness-heat-induced Resolution" in Diabetes Mellitus Traditional Chinese Medicine. Zhejiang Chinese Medicine Journal. 2006;4:242-5.
- Min Liu, Jing Li, Zhangzhi Zhu, Lianyi Dai. Analysis of syndrome of damp-heat syndrome of Diabetes Mellitus. The New Chinese Medicine Journal. 2005;37(9):3-5.
- Taikang Huang, Editor. Traditional Chinese Medicine Treatment for Endocrine Metabolism Disease. Beijing: China Medical Science Press; 2002, p. 459.
- Xinlan Ma. Analysis of Diabetes Mellitus Qi and blood. Liaoning Chinese Medicine Journal. 1997:4:167.
- Korea Institute of Oreintal Medicine. Citrus aurantium A, Korean Intellectual Property Office, 2007; Available from : https://doi.org/10.20929/KTKP.MED.0000080008.
- Doo Ill Han, Bang Yeon Hwang, Suk Yeon Hwang, Jeong Hill PARK, Kun Ho Son, Seung Ho Lee, Seung Yeup Chang, Shin Jung Kang, Jai Seup Ro, Kyong Soon Lee. Isolation and Quantitative Analysis of Hesperidin from Aurantii Fructus. Korean Journal of Pharmacognosy. 2001;32(2):93-7.
- Sundaram R, Nandhakumar E, Haseena Banu H. Hesperidin, a citrus flavonoid ameliorates hyperglycemia by regulating key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats. Toxicol Mech Methods. 2019;29(9):644-53. https://doi.org/10.1080/15376516.2019.1646370
- Xuguang H, Aofei T, Tao L, Longyan Z, Weijian B, Jiao G. Hesperidin ameliorates insulin resistance by regulating the IRS1-GLUT2 pathway via TLR4 in HepG2 cells. Phytother Res. 2019;33(6):1697-1705. https://doi.org/10.1002/ptr.6358
- Hanchang W, Khamchan A, Wongmanee N, Seedadee C. Hesperidin ameliorates pancreatic β-cell dysfunction and apoptosis in streptozotocin-induced diabetic rat model. Life Sci. 2019;235:116858. doi:10.1016/j.lfs.2019.116858.
- Bai L, Li X, He L, et al. Antidiabetic Potential of Flavonoids from Traditional Chinese Medicine: A Review. Am J Chin Med. 2019;47(5):933-57. https://doi.org/10.1142/S0192415X19500496
- Park, Jung-Sup, Park, Chong-Hyeong, Jun, Chan-Yong, Choi, You-Kyung, Hwang, Gwi-Seo, Kim, Dong-Woo. The Anti-diabetes and Vasoelasticity Effects of Mori Folium and Aurantii Fructus in Streptozotocin Induced Type II Diabetes Mellitus Model. The journal of internal Korean medicine 007;28(3):544-59.
- Furman BL. Streptozotocin-Induced Diabetic Models in Mice and Rats. Curr Protoc Pharmacol. 2015;70:5.47.1-5.47.20. doi: 10.1002/0471141755.ph0547s70.
- Aoki K, Sato H, Terauchi Y. Usefulness of antidiabetic alpha-glucosidase inhibitors: a review on the timing of administration and effects on gut hormones. Endocr J. 2019;66(5):395-401. https://doi.org/10.1507/endocrj.EJ19-0041
- Rios JL, Francini F, Schinella GR. Natural Products for the Treatment of Type 2 Diabetes Mellitus. Planta Med. 2015;81(12-13):975-94. https://doi.org/10.1055/s-0035-1546131
- Naveen J, Baskaran V. Antidiabetic plant-derived nutraceuticals: a critical review. Eur J Nutr. 2018;57(4):1275-99. https://doi.org/10.1007/s00394-017-1552-6
- Dhanya R, Jayamurthy P. In vitro evaluation of antidiabetic potential of hesperidin and its aglycone hesperetin under oxidative stress in skeletal muscle cell line. Cell Biochem Funct. 2020;10.1002/cbf.3478. doi:10.1002/cbf.3478.
- Rehman K, Munawar SM, Akash MSH, et al. Hesperidin improves insulin resistance via down-regulation of inflammatory responses: Biochemical analysis and in silico validation. PLoS One. 2020;15(1):e0227637. doi:10.1371/journal.pone.0227637.
- Chen YJ, Kong L, Tang ZZ, et al. Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2/ARE/glyoxalase 1 pathway. Biomed Pharmacother. 2019;111:1166-75. https://doi.org/10.1016/j.biopha.2019.01.030
- Dokumacioglu E, Iskender H, Musmul A. Effect of hesperidin treatment on α-Klotho/FGF-23 pathway in rats with experimentally-induced diabetes. Biomed Pharmacother. 2019;109:1206-10. https://doi.org/10.1016/j.biopha.2018.10.192
- Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137-88. https://doi.org/10.1152/physrev.00045.2011